T. Rowe Price Associates’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $49K | Hold |
|
|||||
|
2024
Q2 | $117K | Hold |
|
|||||
|
2024
Q1 | $121K | Hold |
|
|||||
|
2023
Q4 | $176K | Hold |
|
|||||
|
2023
Q3 | $90K | Hold |
|
|||||
|
2023
Q2 | $72K | Hold |
|
|||||
|
2023
Q1 | $61K | Buy |
|
|||||
|
2022
Q4 | $44K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $78K | Buy |
|
|||||
|
2022
Q1 | $96K | Sell |
|
|||||
|
2021
Q4 | $330K | Buy |
|
|||||
|
2021
Q3 | $219K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $516K | Buy |
|
|||||
|
2020
Q3 | $365K | Buy |
|
|||||
|
2020
Q2 | $240K | Sell |
|
|||||
|
2020
Q1 | $516K | Buy |
|
|||||
|
2019
Q4 | $294K | Sell |
|
|||||
|
2019
Q3 | $801K | Sell |
|
|||||
|
2019
Q2 | $1.32M | Sell |
|
|||||
|
2019
Q1 | $1.44M | Sell |
|
|||||
|
2018
Q4 | $1.73M | Sell |
|
|||||
|
2018
Q3 | $3.9M | Sell |
|
|||||
|
2018
Q2 | $3.34M | Buy |
|
|||||
|
2018
Q1 | $4.25M | Buy |
|
|||||
|
2017
Q4 | $3.02M | Buy |
|
|||||
|
2017
Q3 | $4.54M | Buy |
|